West Nile Virus

Hawaii firm develops vaccine

Published in Vaccine Weekly, August 13th, 2003

A Hawaii research company has developed a vaccine using genetically engineered viral proteins to protect human beings from contracting the West Nile virus.

David Watumull, president and chief executive officer of Hawaii Biotech, said the vaccine produced by the company protected 100% of 60 test animals who were injected with West Nile virus. In contrast, 77% of the 30 control animals died and the others showed some signs of sickness, he said.

Aiea-based Hawaii Biotech, a privately held biopharmaceutical company specializing in drug research and development, was founded in 1982 by nine University of Hawaii professors.

The company...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-08-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry